, /PRNewswire/ — Cortechs.ai, a leader in AI-powered neuroimaging and prostate imaging solutions, is pleased to announce the successful close of an oversubscribed Series C funding round led by VILAS Ventures. This strategic investment will fuel the company’s mission to advance medical imaging through cutting-edge technology, expanding both its product suite and market reach.
The funding round, which exceeded its hard cap by a wide margin, drew strong interest from a diverse group of investors, reflecting high confidence in Cortechs.ai’s innovative solutions. Existing investor Genting Berhad, a global conglomerate, participated in the round as well.
“We are thrilled by the enthusiastic response from our investors,” said Kyle Frye, CEO of Cortechs.ai. “This oversubscribed round is a testament to the growing recognition of the critical role our AI-powered tools play in improving diagnostic confidence and patient outcomes. In selecting VILAS Ventures as our capital partner, we valued their deep understanding of healthcare …